Testosterone Suppression With a Unique Form of Leuprorelin Acetate as a Solid Biodegradable Implant in Patients With Advanced Prostate Cancer: Results From Four Trials and Comparison With the Traditional Leuprorelin Acetate Microspheres Formulation

Therapeutic Advances in Urology - United States
doi 10.1177/1756287217701665
Full Text
Abstract

Available in full text

Categories
Urology
Date
Authors
Publisher

SAGE Publications

Related search

Foreign Body Granulomas Induced by Intramuscular Leuprorelin Acetate Injection for Prostate Cancer: Clinical Mimics of Soft Tissue Sarcoma

Case Reports in Oncological Medicine
Oncology
2015English

The Possible Anti-Inflammatory Role of Circulating Human Leukocyte Antigen Levels in Women With Endometriosis After Treatment With Danazol and Leuprorelin Acetate Depot

Mediators of Inflammation
ImmunologyCell Biology
2001English

PCN97 Pharmacoeconomic Analysis of the Prostate Cancer Therapy With Gonadotropin-Releasing Hormone Analogues: Leuprorelin, Goserelin, Triptorelin

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2012English

Dynamic PET/CT With 11c-Acetate in Prostate Cancer

Journal of Nuclear Medicine
MedicineNuclear MedicineRadiologyImaging
2012English

The First Experience in Using Abiraterone Acetate in Patients With Castration-Refractory Prostate Cancer

Andrologia i Genital'naa Hirurgia
SurgeryReproductive MedicineUrology
2015English

Clinical Studies Investigating the Use of Leuprorelin in Breast Cancer Patients From Asia

Asian Pacific Journal of Cancer Prevention
2019English

Unusual Side Effect From a Luteinizing Hormone-Releasing Hormone Agonist, Leuprorelin, in the Treatment of Prostate Cancer: A Case Report

Journal of Medical Case Reports
Medicine
2016English

Growth Hormone in Combination With Leuprorelin in Pubertal Children With Idiopathic Short Stature

Endocrine Connections
Internal MedicineEndocrinologyMetabolismDiabetes
2018English

Prostate-Specific Antigen Response to Withdrawal of Megestrol Acetate in a Patient With Hormone-Refractory Prostate Cancer

Mayo Clinic Proceedings
Medicine
1997English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy